This comes a day after the aiocd told mediapersons that the country has witnessed an alarming surge in counterfeit medicines flooding retail markets, a spike of nearly 50 per cent over and abovers in. Years. “

The traders ‘body attributed this rises to a combination of factors, including consumers’ preference for high-development drugs, inadequate government vigilance, and “lenient” prohibitive liters.

Addressing a press conference in kolkata on Friday, Sankha Roy Choudway, the official spokesperson of the BCDA, Said, “Post Covid, there has been in an increase in Countryfeit Drugs by 47 purscent. The Reason is implementation of goods and services tax (GST). Before GST Tax Policies were different in different states. After gst, any state from anyWhere is an average to support drugs everywhere. Most of the Medicines which are being seized here are all manfactured out of Bengal – Agra, Delhi, Patna. “

Choudery explained that prior to gst, varying state taxis policies creating barriers to inter-steet drug distribution. The implementation of GST Allowed Easier Movement of Pharmaceuticals Across States. “We are really worried and concerned. We want to fight this manace. Recently, 144 Drugs have been declared as Substandard. If you look at the list of the medicine close, most of it is supplied in hospitals, a rare percentage is solid from our counters. Nearly 60-70 of 144 are manufactured by paschimbanga pharmaceutical, which supplies to hospitals, “He added.

The BCDA has also appeared to all stakeholders to come forward to fight the menace of counterfeit drugs. “The Proliferation of Counterfeit Medicines is a ticking time bomb, and we cannot afford to wait. We urge the government to strengthen regulatory measures, Enhance Enforcement, and the public awareness to combat this mind, “Prithwi Bose, General Security, BCDA, SAID.

Prithwi bose; Sankha Roy Chowdhury, Official Spokesperson, Bengal Chemists & Druggists Association, Mr. Pranab Ghosh, President-BCDA; Debashish Guha, Organizing Secretary-BCDA; Prodyot Banerjee, Admin. Secretary-BCDA and Md. Irfan Khan Lodhi, Treasurer- BCDA was present at the press conference.

As many as 145 drugs from various companies have failed quality assurance tests. Of these, 52 drugs failed the central drug controlry’s tests, while 93 widely used drugs failed state-level drug control tests.

The Central Drugs Standard Control Organization (CDSCO) in Kolkata has identified select batches of these 145 drugs and formulations as “not of standard quality” (NSQ) for january 2025. Hypertension, Allergies and Nausea, as well as sample batches of Glenmark Pharma’s popular hypertension Medication Telma am and alkem health sciences’ ondem-4 tables, used to live nausea and vomiting.

These findings are part of the cdsco’s on the regulatory surveillance, which involves collecting and analyting drug sugles from sales and distribution potints. It publishes a list of spurious drugs on its portal monthly.

In his appeal to all stakeholders to come forward to fight the manace of the counterfeit drugs, Bose Said, “BCDA is calling for a multi-stakeHolder approach on addition this isissue, including. Agencies, Law Enforcement, Healthcare Professionals and Public in General. “

“15% of the total medicines available in the market are fake or counterfeit or illegal which poses a significant threat to public health and safety,” He further said.

BCDA Has Recently Identified Several Cities As HotSpots Where The Production of Spurious and Counterfeit Drugs is Alarmingly High, Sankha Roy Choudhury Said, Adding That Thoricit Druggs Often Frig Unlicensed Individuals, While Licensed Manufacturers May Also Be Involved.

The states’ Weak Regulatory Infrastructure, Insual Testing Facilities, Lack of a Whistle-Blower Scheme, Low Awareness, And Absence of Special Courts are barriers to Effective Action Againous Drugs, Hedded.

“BCDA Urges Authorities at Both State and Central Government Levels To Take Immediate Action To Address This Issue, Specifically, Stepping Up Vigilance in HotSpot Cities To Prevent Bose.